Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;33(6):e14267.
doi: 10.1111/dth.14267. Epub 2020 Sep 28.

Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature

Affiliations
Review

Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature

Sonia Sofia Ocampo-Garza et al. Dermatol Ther. 2020 Nov.

Abstract

Androgenetic alopecia (AGA) is an androgen-dependent hereditary trait resulting in hair miniaturization. It is the most common type of alopecia in men and women. During the last years, multiple treatment modalities have been studied, but only topical minoxidil and finasteride have been approved by the US Food and Drug Administration. Microneedling (MN) is a minimally invasive technique that induces collagen formation, as well as growth factors production and neovascularization. Even though not many studies of MN in alopecia have been performed, it remains a favorable treatment modality; however, no standardized protocol for MN in hair loss has been proposed yet. Current evidence is not sufficient to allow a direct comparison with other therapies, but it shows promises to increase hair density, thickness, and quality of hair, especially when combined with other treatments or when used as a drug delivery system. This article aims to summarize the available literature regarding the use of MN alone or associated with other therapies for the treatment of androgenetic alopecia.

Keywords: androgenetic alopecia; collagen induction therapy; dermaroller; hair loss; microneedling; needling dermabrasion; pattern hair loss.

PubMed Disclaimer

References

REFERENCES

    1. Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al.. S3-European Dermatology Forum Guideline for the Treatment of Androgenetic Alopecia in Women and in Men. 2018;1-59.
    1. Sinclair R, Torkamani N, Jones L. Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. F1000Res. 2015;4:585.
    1. Saed S, Ibrahim O, Bergfeld WF. Hair camouflage: a comprehensive review. Int J Womens Dermatol. 2017;3:S75-S80.
    1. Alfonso M, Richter-Appelt H, Tosti A, Viera MS, García M. The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin. 2005;21:1829-1836.
    1. Manabe M, Tsuboi R, Itami S, et al. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. J Dermatol. 2018;45:1031-1043.

LinkOut - more resources